सिगाची इंडस्ट्रीज शेअर किंमत

<h3><span style="font-size:16px;"><strong>फार्मास्युटिकल्स कंपनी सिगाची इंडस्ट्रीजने Q1FY27 परिणाम घोषित केले</strong></span></h3><p _ngcontent-ng-c1940132427=""><strong _ngcontent-ng-c1940132427="">एकत्रित फायनान्शियल हायलाईट्स:</strong></p><ul><li _ngcontent-ng-c1940132427="">Revenue from Operations for Q1FY27 stood at Rs 12,127.38 lakh, reflecting a decrease of 5.44% from Rs 12,824.62 lakh in Q1FY26 and a marginal decline of 0.51% from Rs 12,189.51 लाख Q4FY26 मध्ये.</li><li _ngcontent-ng-c1940132427="">एकूण इन्कम ₹12,227.67 पर्यंत पोहोचले lakh in Q1FY27, representing a YoY decline of 7.50% compared to Rs 13,218.94 lakh in Q1FY26 and a 0.78% decrease from Rs 12,324.22 लाख Q4FY26 मध्ये.</li><li _ngcontent-ng-c1940132427="">Profit before tax (PBT) was Rs 1,008.97 lakh in Q1FY27, a significant turnaround compared to a loss of Rs 10,099.29 lakh in Q1FY26. On a QoQ basis, PBT increased by 30.82% from Rs 771.29 lakh in Q4FY26.</li><li _ngcontent-ng-c1940132427="">Profit for the period (PAT) was Rs 814.47 lakh in Q1FY27, compared to a loss of Rs 10,097.08 लाख Q1FY26 मध्ये. PAT grew by 6.49% on a QoQ basis from Rs 764.81 lakh in Q4FY26.</li></ul><p><strong _ngcontent-ng-c1940132427="">स्टँडअलोन फायनान्शियल हायलाईट्स:</strong></p><ul><li _ngcontent-ng-c1940132427="">Q1FY27 साठी कामकाजाचा महसूल ₹ 9,827.58 होता lakh, down 11.45% YoY from Rs 11,097.65 lakh in Q1FY26 and up 6.71% QoQ compared to Rs 9,209.51 लाख Q4FY26 मध्ये.</li><li _ngcontent-ng-c1940132427="">एकूण इन्कम ₹9,871.92 होते Q1FY27 मध्ये लाख, वार्षिक 14.10% घट ₹ 11,491.74 पासून lakh in Q1FY26 and a 5.67% increase over Rs 9,342.22 lakh in Q4FY26.</li><li _ngcontent-ng-c1940132427="">Profit for the period (PAT) reached Rs 650.67 lakh in Q1FY27, compared to a loss of Rs 9,914.49 लाख Q1FY26 मध्ये. PAT rose by 32.65% QoQ from Rs 490.50 lakh in Q4FY26.</li></ul><p><strong _ngcontent-ng-c1940132427="">बिझनेस हायलाईट्स:</strong></p><ul><li _ngcontent-ng-c1940132427="">Consolidated Segment Revenue:<ul><li _ngcontent-ng-c1940132427="">Pharmaceuticals: Rs 10,821.40 लाख Q1FY27 मध्ये.</li><li _ngcontent-ng-c1940132427="">Operational and Management: Rs 1,305.97 लाख Q1FY27 मध्ये.</li></ul></li><li _ngcontent-ng-c1940132427="">Consolidated Segment Results (Profit before tax and interest):<ul><li _ngcontent-ng-c1940132427="">Pharmaceuticals: Rs 1,081.67 lakh in Q1FY27.</li><li _ngcontent-ng-c1940132427="">Operational and Management: Rs 228.61 lakh in Q1FY27.</li></ul></li><li _ngcontent-ng-c1940132427="">Standalone Segment Revenue:<ul><li _ngcontent-ng-c1940132427="">Pharmaceuticals: Rs 8,521.61 लाख Q1FY27 मध्ये.</li><li _ngcontent-ng-c1940132427="">Operational and Management: Rs 1,305.97 लाख Q1FY27 मध्ये.</li></ul></li><li _ngcontent-ng-c1940132427="">Standalone Segment Results (Profit before tax and interest):<ul><li _ngcontent-ng-c1940132427="">Pharmaceuticals: Rs 769.35 lakh in Q1FY27.</li><li _ngcontent-ng-c1940132427="">Operational and Management: Rs 228.61 lakh in Q1FY27.</li></ul></li><li _ngcontent-ng-c1940132427="">Forfeiture of Warrants: The company approved the forfeiture of 3,50,57,990 convertible warrants as the conversion option was not exercised within the 18-month tenure ending February 09, 2025. Consequently, the 25% upfront consideration amounting to Rs 22,87,53,813 has been forfeited.</li><li _ngcontent-ng-c1940132427="">IPO Proceeds Utilization: Funds allocated for MCC production capacity expansion at Dahej (Rs 2,815.82 lakh) and Jhagadia (Rs 2,924.13 lakh) were fully utilized by Q4FY23. A remaining unutilized balance of Rs 3,229.87 lakh is available for the CCS project at Dahej.</li><li _ngcontent-ng-c1940132427="">Board Appointments: Ms. Dhanalakshmi Guntaka and Mr. Janardhana Reddy Yeddula were re-appointed as Independent Directors for a second five-year term, effective from October 18, 2026, and November 30, 2026, respectively.</li></ul><p><a class="lb" href="/marathi/get-document/post/pdf/5788047/" target="_blank">रिझल्ट PDF</a></p>

• ट्रेंडलाईन
• 2 दिवस 15 तासांपूर्वी

वृत्तपत्र प्रकाशन

• बीएसई इंडिया
• 2 दिवस 16 तासांपूर्वी

जून 30, 2026 रोजी समाप्त झालेल्या तिमाहीसाठी मॉनिटरिंग एजन्सी रिपोर्ट

• बीएसई इंडिया
• 3 दिवस 9 तासांपूर्वी